Sartorius To Acquire Albumedix, Creating A Powerhouse For Innovative Advanced Therapy Solutions
08/09/22, 8:15 AM
Albumedix Ltd. ( ́Albumedix ́), a recognized leader in recombinant human albumin-based solutions, today announced that it has entered into a definitive agreement to be acquired by life science group Sartorius, an international leader in laboratory and bioprocessing technologies for the biopharmaceutical industry. Through this acquisition, Albumedix and Sartorius expand their solution space with complementary technologies and synergetic competencies, to deliver science-enabled solutions for the entire advanced therapy value chain.
Company Info
Related People
New Feature: Generate AI-Powered Emails Instantly!
Use one of the following options:
- Click the AI button next to your contact's email to generate a draft automatically.
- Use Copy to Clipboard to paste the email into your favorite email service.
- Click Send via Webmail to use Gmail or another online client.
Important: If nothing happens when you click, you might not have a default email client set up.